Meeting Report: Moving Upstream—Evaluating Adverse Upstream End Points for Improved Risk Assessment and Decision-Making
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Assessing adverse effects from environmental chemical exposure is integral to public health policies. Toxicology assays identifying early biological changes from chemical exposure are increasing our ability to evaluate links between early biological disturbances and subsequent overt downstream effects. A workshop was held to consider how the resulting data inform consideration of an "adverse effect" in the context of hazard identification and risk assessment. OBJECTIVES: Our objective here is to review what is known about the relationships between chemical exposure, early biological effects (upstream events), and later overt effects (downstream events) through three case studies (thyroid hormone disruption, antiandrogen effects, immune system disruption) and to consider how to evaluate hazard and risk when early biological effect data are available. DISCUSSION: Each case study presents data on the toxicity pathways linking early biological perturbations with downstream overt effects. Case studies also emphasize several factors that can influence risk of overt disease as a result from early biological perturbations, including background chemical exposures, underlying individual biological processes, and disease susceptibility. Certain effects resulting from exposure during periods of sensitivity may be irreversible. A chemical can act through multiple modes of action, resulting in similar or different overt effects. CONCLUSIONS: For certain classes of early perturbations, sufficient information on the disease process is known, so hazard and quantitative risk assessment can proceed using information on upstream biological perturbations. Upstream data will support improved approaches for considering developmental stage, background exposures, disease status, and other factors important to assessing hazard and risk for the whole population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Haddow, J. E., Palomaki, G. E., Allan, W. C., Williams, J. R., Knight, G. J., Gagnon, J., O'Heir, C. E., Mitchell, M. L., Hermos, R. J., Waisbren, S. E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410801 · Cited by 2,558
Psychological Stress and Susceptibility to the Common Cold
Cohen, S., Tyrrell, D. A. J., & Smith, A. P. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108293250903 · Cited by 1,712 · cited 2×
“of infectious or neoplastic diseases (Cohen et al. 1991; Kiecolt-Glaser et al. 2002).”
Decrease in anogenital distance among male infants with prenatal phthalate exposure
Swan, S. H., Main, K. M., Liu, F., Stewart, S. L., Kruse, R. L., Calafat, A. M., Mao, C. S., Redmon, J. B., Ternand, C. L., Sullivan, S., et al. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.8100 · Cited by 1,586
Gray, L. E. (2000) · Toxicological Sciences · doi:10.1093/toxsci/58.2.350 · Cited by 1,084
Self-citationVulsma, T., Gons, M. H., & de Vijlder, J. J. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198907063210103 · Cited by 795
Main, K. M., Mortensen, G. K., Kaleva, M. M., Boisen, K. A., Damgaard, I. N., Chellakooty, M., Schmidt, I. M., Suomi, A.-M., Virtanen, H. E., Petersen, J. H., et al. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.8075 · Cited by 696 · cited 1×
“…outcomes, including shortened anogenital distance in male infants prenatally exposed to phthalates (Swan et al. 2005), changes in reproductive hormone levels in male infants exposed to phthalates in breast milk (Main et al. 2006), and poor semen quality in adult males (Hauser et al. 2006).”
Andersen, S., Pedersen, K. M., Bruun, N. H., & Laurberg, P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8165 · Cited by 686 · cited 2×
“Consequently, a TH value within the population reference range is not necessarily normal or healthy for the individual (Andersen et al. 2002), and TH changes within the normal population range may therefore be associated with adverse effects for some individuals.”
Transforming Environmental Health Protection
Collins, F. S., Gray, G. M., & Bucher, J. R. (2008) · Science · doi:10.1126/science.1154619 · Cited by 630
Hauser, R., Meeker, J. D., Duty, S., Silva, M. J., & Calafat, A. M. (2006) · Epidemiology · doi:10.1097/01.ede.0000235996.89953.d7 · Cited by 424 · cited 1×
“Antibody responses to tetanus toxoid vaccine were significantly decreased after early postnatal PCB exposure (Heilmann et al. 2006).”
Aoki, Y., Belin, R. M., Clickner, R., Jeffries, R., Phillips, L., & Mahaffey, K. R. (2007) · Thyroid · doi:10.1089/thy.2006.0235 · Cited by 390
Åsvold, B. O., Vatten, L. J., Nilsen, T. I. L., & Bjøro, T. (2007) · European Journal of Endocrinology · doi:10.1530/eje.1.02333 · Cited by 350
Åsvold, B. O., Bjøro, T., Nilsen, T. I. L., & Vatten, L. J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2208 · Cited by 215
Selva, K. A., Harper, A., Downs, A., Blasco, P. A., & LaFranchi, S. H. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.07.024 · Cited by 190 · cited 2×
“Children diagnosed with congenital hypothyroidism are treated with T4, and even small doses (e.g., 2 µg/kg/day) significantly improve later cognitive performance, demonstrating the sensitivity of the developing brain to TH insufficiency (Oerbeck et al. 2003; Selva et al. 2005).”
Oerbeck, B., Sundet, K., Kase, B. F., & Heyerdahl, S. (2003) · Pediatrics · doi:10.1542/peds.112.4.923 · Cited by 176
Cited by
Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines
Dobrovolskaia, M. A., & McNeil, S. E. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.05.025 · Cited by 309
Woodruff, T. J., Sutton, P., & The Navigation Guide Work Group (2011) · Health Affairs · doi:10.1377/hlthaff.2010.1219 · Cited by 134
Self-citationPutative adverse outcome pathways relevant to neurotoxicity
Bal-Price, A., Crofton, K. M., Sachana, M., Shafer, T. J., Behl, M., Forsby, A., Hargreaves, A., Landesmann, B., Lein, P. J., Louisse, J., et al. (2015) · Critical Reviews in Toxicology · doi:10.3109/10408444.2014.981331 · Cited by 114
Self-citationEndocrine-disrupting chemicals and child health
Ghassabian, A., Vandenberg, L., Kannan, K., & Trasande, L. (2022) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-021921-093352 · Cited by 112
A Mechanistic, Model‐Based Approach to Safety Assessment in Clinical Development
Lippert, J., Brosch, M., von Kampen, O., Meyer, M., Siegmund, H. ‐., Schafmayer, C., Becker, T., Laffert, B., Görlitz, L., Schreiber, S., et al. (2012) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2012.14 · Cited by 43
Metadata
- Authors
- Woodruff, T. J., Zeise, L., Axelrad, D. A., Guyton, K. Z., Janssen, S., Miller, M., Miller, G. G., Schwartz, J. M., Alexeeff, G., Anderson, H., Birnbaum, L., Bois, F., Cogliano, V. J., Crofton, K., Euling, S. Y., Foster, P. M. D., Germolec, D. R., Gray, E., Hattis, D. B., Kyle, A. D., Luebke, R. W., Luster, M. I., Portier, C., Rice, D. C., Solomon, G., Vandenberg, J., & Zoeller, R. T.
- Venue
- Environmental Health Perspectives
- Publisher
- American Chemical Society (ACS)
- Published
- 2008-11
- Volume
- 116
- Issue
- 11
- Pages
- 1568-1575
- ISSN
- 0091-6765 (ISSN-L)
- 1552-9924
- OpenAlex
- W2003357955
- Cited by
- 78
- References
- 14
- FWCI
- 3.45
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.